Turkey launches investigation into 19 pharma cos Ruchika Sharma1 Dec 2023 12:49 PM ISTAnkara: Turkey's competition authority said on Thursday it had launched an investigation into 19 pharmaceutical companies to determine whether they...
Lupin Dapagliflozin Tablets gets tentative USFDA okay Ruchika Sharma22 Nov 2023 1:30 PM ISTDapagliflozin Tablets are used for the treatment of type 2 diabetes.
AstraZeneca unveils health tech business Evinova Ruchika Sharma21 Nov 2023 1:30 PM ISTEvinova will provide established technology solutions to pharma, biotech and CROs to support clinical research globally.
AstraZeneca Imfinzi plus chemotherapy approved in China for locally advanced or metastatic biliary tract cancer Ruchika Sharma19 Nov 2023 11:45 AM ISTImfinzi (durvalumab) is a human monoclonal antibody that binds to the PD-L1 protein and blocks the interaction of PD-L1 with the PD-1 and CD80...
Truqap plus Faslodex approved in US for advanced HR-positive breast cancer: AstraZeneca Ruchika Sharma18 Nov 2023 2:14 PM ISTCambridge: AstraZeneca’s Truqap (capivasertib) in combination with Faslodex (fulvestrant) has been approved in the US for the treatment of adult...
AstraZeneca Pharma India plans to sell Bengaluru facility Ruchika Sharma17 Nov 2023 3:30 PM ISTBengaluru: AstraZeneca Pharma India plans to sell its production facility in Bengaluru as part of a strategic review of global manufacturing and...
AstraZeneca breast cancer drug combination gets USFDA okay Ruchika Sharma17 Nov 2023 11:37 AM ISTTruqap belongs to a class of drugs known as AKT inhibitors and works by targeting the AKT1 gene mutation, which is responsible for growth and...
AstraZeneca-Oxford COVID vaccine faces legal challenge in UK, says Report Ruchika Sharma14 Nov 2023 4:15 PM ISTLondon: The Oxford-AstraZeneca COVID-19 vaccine, known as Vaxzevria in Europe and licensed as Covishield in India, is facing a legal...
AstraZeneca licenses novel agent for treatment of cardiometabolic conditions, obesity Ruchika Sharma13 Nov 2023 3:00 PM ISTCambridge: AstraZeneca and Eccogene have entered into an exclusive licence agreement for ECC5004, an investigational oral once-daily...
AstraZeneca joins hands with Cellectis to accelerate development of next generation therapeutics Ruchika Sharma5 Nov 2023 4:00 PM ISTAstraZeneca has announced a collaboration and investment agreement with Cellectis, a clinical-stage biotechnology company, to accelerate the...
Zibotentan plus dapagliflozin demonstrated significant albuminuria reduction in patients with chronic kidney disease, proteinuria: AstraZeneca Ruchika Sharma5 Nov 2023 1:00 PM ISTCambridge: AstraZeneca has announced that the combination of zibotentan with dapagliflozin has shown statistically significant and clinically...
AstraZeneca gets CDSCO Panel Nod To Import, Market Andexanet alfa powder for solution for infusion Dr. Divya Colin27 Oct 2023 6:00 PM ISTNew Delhi: Pharmaceutical major AstraZeneca has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
